Global News

X-Chem achieves milestones, licenses drug discovery programs to AstraZeneca

Wednesday, September 25, 2013 02:43 PM

X-Chem, a privately-held biotechnology company focused on applying its drug discovery capabilities to the generation of novel small molecule therapeutics, has achieved several milestones leading to the licensing of three drug discovery programs by AstraZeneca, in the context of a collaboration the companies established in May 2012.

More... »

Wolters Kluwer Health launches Lippincott mobile nursing app

Wednesday, September 25, 2013 12:37 PM

Wolters Kluwer Health, a global provider of information and point-of-care solutions, has launched the Lippincott’s Nursing Advisor app, the first mobile application of an online clinical decision support solution for nurses. 

More... »

Covance launches external laboratory management services

Wednesday, September 25, 2013 12:36 PM

CRO Covance has launched external laboratory management services, a new offering that provides biopharmaceutical companies with a management solution for external laboratory testing associated with clinical trials.

More... »

Servier makes offer for all shares of Egis Pharmaceuticals

Wednesday, September 25, 2013 12:31 PM

Servier Group has announced a voluntary public offer (to be made by its wholly-owned subsidiary Arts et Techniques du Progrès) to purchase all outstanding shares in its majority-owned subsidiary Egis Pharmaceuticals for $126 per share in cash.

More... »

Sysmex acquires Inostics

Wednesday, September 25, 2013 12:29 PM

Privately-held biotech company Indivumed, based in Hamburg, Germany, has announced that Inostics and its Baltimore-based subsidiary have been sold to Sysmex, a developer and manufacturer of instruments, reagents and software needed for in-vitro diagnostics, headquartered in Japan.

More... »

WCCT Global acquires OC Clinical Trials and Consulting

Wednesday, September 25, 2013 12:28 PM

WCCT Global, an Orange County, Calif.-based CRO, has acquired OC Clinical Trials and Consulting, an early stage ophthalmology and cosmetology research practice.

More... »

AbbVie, Galapagos to co-develop cystic fibrosis therapies

Wednesday, September 25, 2013 12:24 PM

Galapagos and AbbVie have entered into a global alliance to discover, develop and commercialize novel potentiator and combination therapies in cystic fibrosis (CF), an inherited chronic disease that affects 70,000 people worldwide.

More... »

PRA, RPS merger completed

Wednesday, September 25, 2013 12:23 PM

CRO PRA International has completed its merger with ReSearch Pharmaceutical Services (RPS) and the closing of the acquisition by Kohlberg Kravis Roberts.  

More... »

Janssen, PATH collaborate for Rilpivirine

Wednesday, September 25, 2013 12:21 PM

Janssen R&D Ireland has signed a license agreement with PATH for the early development of the human immunodeficiency virus type 1 (HIV-1) medicine rilpivirine in a long-acting injection (depot formulation) as potential pre-exposure prophylaxis (PrEP) against HIV infection.

More... »

inVentiv Health Clinical launches physician network for late-stage research

Tuesday, September 24, 2013 12:43 PM

inVentiv Health Clinical, a global supplier of drug development services, has launched a web-based network to connect physicians interested in participating in late-stage research to appropriate clinical trials.

More... »